For: | Matsuoka T, Yashiro M. Precision medicine for gastrointestinal cancer: Recent progress and future perspective. World J Gastrointest Oncol 2020; 12(1): 1-20 [PMID: 31966910 DOI: 10.4251/wjgo.v12.i1.1] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v12/i1/1.htm |
Number | Citing Articles |
1 |
Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura, Hiroki Yukami, Saori Mishima, Hideaki Bando, Hiromichi Shirasu, Kentaro Yamazaki, Jun Watanabe, Masahito Kotaka, Keiji Hirata, Naoya Akazawa, Kozo Kataoka, Shruti Sharma, Vasily N. Aushev, Alexey Aleshin, Toshihiro Misumi, Hiroya Taniguchi, Ichiro Takemasa, Takeshi Kato, Masaki Mori, Takayuki Yoshino. Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer. Nature Medicine 2023; 29(1): 127 doi: 10.1038/s41591-022-02115-4
|
2 |
Jinlong Zhang, Yanyu Chen, Bo Chen, Dajuan Sun, Zhen Sun, Junwei Liang, Jing Liang, Xin Xiong, Hua Yan. The dual effect of endoplasmic reticulum stress in digestive system tumors and intervention of Chinese botanical drug extracts: a review. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1339146
|
3 |
Ryan Woodhouse, Meijuan Li, Jason Hughes, David Delfosse, Joel Skoletsky, Pei Ma, Wei Meng, Ninad Dewal, Coren Milbury, Travis Clark, Amy Donahue, Dan Stover, Mark Kennedy, Jennifer Dacpano-Komansky, Christine Burns, Christine Vietz, Brian Alexander, Priti Hegde, Lucas Dennis, Patrick Ha. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLOS ONE 2020; 15(9): e0237802 doi: 10.1371/journal.pone.0237802
|
4 |
Catalina M. Perelló-Reus, Teresa Rubio-Tomás, Eugenia Cisneros-Barroso, Lesly Ibargüen-González, Juan José Segura-Sampedro, Rafael Morales-Soriano, Carles Barceló. Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.995357
|
5 |
Kimberley Clack, Narshone Soda, Surasak Kasetsirikul, Rabbee G. Mahmudunnabi, Nam‐Trung Nguyen, Muhammad J. A. Shiddiky. Toward Personalized Nanomedicine: The Critical Evaluation of Micro and Nanodevices for Cancer Biomarker Analysis in Liquid Biopsy. Small 2023; 19(15) doi: 10.1002/smll.202205856
|
6 |
Grace Ann Hanvey, Elizabeth L. Kacel, Kelsey C. Bacharz, Adaixa Padrón Wilborn, Sonia Mesa, Halle McCracken, Irene M. Estores, Merry-Jennifer Markham, Frederic J. Kaye, Dennie Jones, Thomas J. George, Deidre B. Pereira. Proof-of-Concept of an Integrated Yoga and Psychological Intervention in Mitigating Distress Among Diverse Women With Gynecologic, Gastrointestinal, and Thoracic Cancers. Integrative Cancer Therapies 2024; 23 doi: 10.1177/15347354241283113
|
7 |
Samuel Amintas, Charles Dupin, Julian Boutin, Pauline Beaumont, François Moreau-Gaudry, Aurélie Bedel, Stéphanie Krisa, Véronique Vendrely, Sandrine Dabernat. Bioactive food components for colorectal cancer prevention and treatment: A good match. Critical Reviews in Food Science and Nutrition 2023; 63(23): 6615 doi: 10.1080/10408398.2022.2036095
|
8 |
Xin Qi, Xingqi Chen, Yuanchun Zhao, Jiajia Chen, Beifang Niu, Bairong Shen. Prognostic Roles of ceRNA Network-Based Signatures in Gastrointestinal Cancers. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.921194
|
9 |
Tajul Islam Mamun, Sabrina Younus, Md. Hashibur Rahman. Gastric cancer—Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review. Cancer Treatment and Research Communications 2024; 41: 100845 doi: 10.1016/j.ctarc.2024.100845
|
10 |
Alexander Baraniskin, Hideo A. Baba, Dirk Theegarten, Thomas Mika, Roland Schroers, Susanne Klein-Scory. Liquid biopsy can cure early colorectal cancer recurrence – Case Report. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1141833
|
11 |
Janeesh Sekkath Veedu, Jill Kolesar, Chaitanya Iragavarapu. Precision Oncology in Colorectal Cancers- Therapeutics and Beyond (CME article). International Journal of Cancer Care and Delivery 2022; 2(1) doi: 10.53876/001c.33571
|
12 |
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Kohei Horimoto, Satoshi Yajima, Masakazu Yashiro, Keigo Yokoi, Haruhiko Cho, Takuya Ehira, Kazunari Nakahara, Hiroshi Yasuda, Kazutoshi Isobe, Tetsu Hayashida, Shingo Hatakeyama, Koichiro Akakura, Daisuke Aoki, Hiroyuki Nomura, Yuji Tada, Yuki Yoshimatsu, Hayato Miyachi, Chiaki Takebayashi, Ichiro Hanamura, Hiroyuki Takahashi. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2. International Journal of Clinical Oncology 2024; 29(5): 512 doi: 10.1007/s10147-024-02497-0
|
13 |
Luciana Santos Pessoa, Manoela Heringer, Valéria Pereira Ferrer. ctDNA as a cancer biomarker: A broad overview. Critical Reviews in Oncology/Hematology 2020; 155: 103109 doi: 10.1016/j.critrevonc.2020.103109
|
14 |
Michele Ghidini. New Tools for Precision and Personalized Treatment in Gastrointestinal Cancers. Gastrointestinal Disorders 2021; 3(4): 204 doi: 10.3390/gidisord3040019
|
15 |
Pankaj Musyuni, Jing Bai, Afsana Sheikh, Kirthanashri S. Vasanthan, Gaurav Kumar Jain, Mohammed A.S. Abourehab, Viney Lather, Geeta Aggarwal, Prashant Kesharwani, Deepti Pandita. Precision medicine: Ray of hope in overcoming cancer multidrug resistance. Drug Resistance Updates 2022; 65: 100889 doi: 10.1016/j.drup.2022.100889
|
16 |
Hua-Yang Pang, Xiu-Feng Chen, Meng-Hua Yan, Li-Hui Chen, Zhi-Xiong Chen, Shou-Ru Zhang, Hao Sun. Clinical significance of the advanced lung cancer inflammation index in gastrointestinal cancer patients: a systematic review and meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1021672
|
17 |
Massimiliano Salati, Konstantinos Venetis, Matteo Fassan, Umberto Malapelle, Fabio Pagni, Elham Sajjadi, Nicola Fusco, Michele Ghidini. ctDNA Analysis in the Personalized Clinical Management of Gastroesophageal Adenocarcinoma: Turning Hope Into Reality. Future Oncology 2021; 17(33): 4607 doi: 10.2217/fon-2021-0228
|
18 |
Faisal Binzagr. Explainable AI-driven model for gastrointestinal cancer classification. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1349373
|
19 |
Gang Wang, Tao Liu, Wen-Ting He. Visualization analysis of research hotspots and trends on gastrointestinal tumor organoids. World Journal of Gastrointestinal Oncology 2024; 16(6): 2826-2841 doi: 10.4251/wjgo.v16.i6.2826
|
20 |
Puneet Singla, Pankaj Musyuni, Geeta Aggarwal, Harjinder Singh. Precision Medicine: An Emerging Paradigm for Improved Diagnosis and Safe Therapy in Pediatric Oncology. Cureus 2021; doi: 10.7759/cureus.16489
|
21 |
Jing Gao, Jianqiang Lan, Haiyan Liao, Fang Yang, Pei Qiu, Feng Jin, Shubin Wang, Lin Shen, Tengfei Chao, Cheng Zhang, Yu Zhu. Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11434-9
|
22 |
Monica Augustyniak, Emil Lou, Ginny Jacobs, Matthew Fleming, John Marshall, Anelisa Coutinho, Takayuki Yoshino. Learning Outcomes of “GetSMART,” Education for Diagnostics and Targeted Treatment for HER2+ Metastatic Gastric and Colorectal Cancers. Journal of Cancer Education 2024; 39(2): 118 doi: 10.1007/s13187-023-02384-8
|
23 |
Tasuku Matsuoka, Masakazu Yashiro. Current status and perspectives of genetic testing in gastrointestinal cancer (Review). Oncology Letters 2023; 27(1) doi: 10.3892/ol.2023.14155
|
24 |
Pashtoon Murtaza Kasi, Sarah Sawyer, Jessica Guilford, Michelle Munro, Sascha Ellers, Jacob Wulff, Nicole Hook, Shifra Krinshpun, Allyson Koyen Malashevich, Meenakshi Malhotra, Angel Rodriguez, Solomon Moshkevich, Axel Grothey, Scott Kopetz, Paul Billings, Alexey Aleshin. BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer. BMJ Open 2021; 11(9): e047831 doi: 10.1136/bmjopen-2020-047831
|
25 |
Masakazu Yashiro, Kenji Kuroda, Go Masuda, Tomohisa Okuno, Yuichiro Miki, Yurie Yamamoto, Tomohiro Sera, Atsushi Sugimoto, Shuhei Kushiyama, Sadaaki Nishimura, Shingo Togano, Masaichi Ohira. Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84107-x
|
26 |
Sara Memarpour, Ghazaleh Khalili-Tanha, Awa Alizadeh Ghannad, Masoud Sharifian Razavi, Mona Joudi, Marjan Joodi, Gordon A. Ferns, Seyed Mahdi Hassanian, Majid Khazaei, Amir Avan. The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer. Current Cancer Drug Targets 2021; 21(8): 676 doi: 10.2174/1568009621666210311090531
|
27 |
Worawat Songjang, Chatchai Nensat, Sutatip Pongcharoen, Arunya Jiraviriyakul. The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review). Biomedical Reports 2021; 15(4) doi: 10.3892/br.2021.1462
|
28 |
Athanasios Armakolas, Maria Kotsari, John Koskinas. Liquid Biopsies, Novel Approaches and Future Directions. Cancers 2023; 15(5): 1579 doi: 10.3390/cancers15051579
|
29 |
Hiroyuki Yamamoto, Yoshiyuki Watanabe, Yoshinori Sato, Tadateru Maehata, Fumio Itoh. Non-Invasive Early Molecular Detection of Gastric Cancers. Cancers 2020; 12(10): 2880 doi: 10.3390/cancers12102880
|
30 |
Raghad Khalid AL-Ishaq, Alena Mazurakova, Peter Kubatka, Dietrich Büsselberg. Flavonoids’ Dual Benefits in Gastrointestinal Cancer and Diabetes: A Potential Treatment on the Horizon?. Cancers 2022; 14(24): 6073 doi: 10.3390/cancers14246073
|
31 |
Tasuku Matsuoka, Masakazu Yashiro. Molecular Insight into Gastric Cancer Invasion—Current Status and Future Directions. Cancers 2023; 16(1): 54 doi: 10.3390/cancers16010054
|